Activist 13D/13G Filings - ORBIMED ADVISORS LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, ...14, 15, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2023-05-05
11:14 am
Unchanged		13DXTANT MED HLDGS INC
XTNT		ORBIMED ADVISORS LLC73,114,592
67.1%		0
(Unchanged)		View
2023-05-02
7:28 pm
Purchase		13DKINNATE BIOPHARMA INC
KNTE		ORBIMED ADVISORS LLC6,098,797
13.1%		1,405,168increase
(+29.94%)		View
2023-04-21
5:03 pm
Sale		13DTELA BIO INC
TELA		ORBIMED ADVISORS LLC2,866,267
11.9%		-192,000decrease
(-6.28%)		View
2023-04-11
7:10 pm
Purchase		13DAPOLLOMICS INC. USD SHS
APLM		ORBIMED ADVISORS LLC662,561
10.3%		662,561increase
(New Position)		View
2023-04-07
4:38 pm
Sale		13DGALECTO INC
GLTO		ORBIMED ADVISORS LLC2,696,654
10.5%		-74,790decrease
(-2.70%)		View
2023-03-31
4:48 pm
Purchase		13DGRACELL BIOTECHNOLOGIES INC SP
GRCL		ORBIMED ADVISORS LLC7,583,576
11.2%		1,612,904increase
(+27.01%)		View
2023-03-29
5:24 pm
Unchanged		13DTERNS PHARMACEUTICALS INC
TERN		ORBIMED ADVISORS LLC7,619,135
13.4%		0
(Unchanged)		View
2023-03-24
4:57 pm
Unchanged		13DCALCIMEDICA INC
CALC		ORBIMED ADVISORS LLC297,380
5.4%		0
(Unchanged)		View
2023-03-24
4:43 pm
Sale		13D89BIO INC
ETNB		ORBIMED ADVISORS LLC0
0%		-1,504,436decrease
(Position Closed)		View
2023-03-22
4:27 pm
Purchase		13DCALCIMEDICA INC
CALC		ORBIMED ADVISORS LLC297,380
18.9%		297,380increase
(New Position)		View
2023-03-14
4:19 pm
Purchase		13DTHESEUS PHARMACEUTICALS INC CO
THRX		ORBIMED ADVISORS LLC17,233,668
39.6%		395,000increase
(+2.35%)		View
2023-02-28
5:09 pm
Sale		13DFUSION PHARMACEUTICALS INC
FUSN		ORBIMED ADVISORS LLC2,930,670
4.7%		-67,311decrease
(-2.25%)		View
2023-02-28
4:00 pm
Purchase		13DENLIVEN THERAPEUTICS INC
ELVN		ORBIMED ADVISORS LLC8,949,339
21.8%		8,949,339increase
(New Position)		View
2023-02-23
3:23 pm
Purchase		13DKINNATE BIOPHARMA INC
KNTE		ORBIMED ADVISORS LLC4,693,629
10.6%		1,295,700increase
(+38.13%)		View
2023-02-14
5:24 pm
Purchase		13GX4 PHARMACEUTICALS INC
XFOR		ORBIMED ADVISORS LLC10,328,649
8.2%		8,492,300increase
(+462.46%)		View
2023-02-14
5:20 pm
Sale		13GVISTAGEN THERAPEUTICS, INC. CO
VTGN		ORBIMED ADVISORS LLC0
0%		-10,519,240decrease
(Position Closed)		View
2023-02-14
5:16 pm
Purchase		13GVERASTEM, INC.
VSTM		ORBIMED ADVISORS LLC16,503,237
7.9%		16,503,237increase
(New Position)		View
2023-02-14
5:12 pm
Purchase		13GVECTIVBIO HLDG AG
VECT		ORBIMED ADVISORS LLC6,713,561
10.7%		1,810,057increase
(+36.91%)		View
2023-02-14
5:07 pm
Sale		13GTHERAVANCE BIOPHARMA INC
TBPH		ORBIMED ADVISORS LLC0
0%		-5,456,780decrease
(Position Closed)		View
2023-02-14
5:04 pm
Sale		13GSONENDO INC
SONX		ORBIMED ADVISORS LLC0
0%		-1,968,180decrease
(Position Closed)		View
Goto Prev, 0, 1, 2, 3, 4, 5, ...14, 15, Next